Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Tff Pharmaceuticals, Inc. (TFFP)  
$0.32 0.00 (0.00%) as of 4:30 Mon 12/18


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 18,450,000
Market Cap: 5.90(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.22 - $0.49
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   TFF Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and commercializing drug products based on its patented Thin Film Freezing technology platform. Co. has two product candidates under development, TFF Voriconazole Inhalation Powder and TFF Tacrolimus Inhalation Powder. Co. is engaged in the joint development of an inhaled SARS-CoV2 Monoclonal Antibody in collaboration with Augmenta Bioworks, Inc. and a dry powder formulation of niclosamide in collaboration agreement with UNION therapeutics A/S. Co. is also engaged in the analysis and testing of dry powder formulations of several drugs and vaccines through topical, ocular and nasal applications.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 820,000 1,103,470
Total Buy Value $0 $0 $205,000 $472,016
Total People Bought 0 0 6 7
Total Buy Transactions 0 0 6 12
Total Shares Sold 0 0 216,000 256,255
Total Sell Value $0 $0 $94,433 $267,127
Total People Sold 0 0 1 2
Total Sell Transactions 0 0 2 3
End Date 2024-03-07 2023-12-05 2023-06-06 2022-06-06

   
Records found: 93
  Page 4 of 4  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Mattes Glenn R. President and CEO   •       •      –    2020-09-25 4 AS $17.00 $51,000 I/I (3,000) 7,000 11%     
   Fletcher Aaron G.l. Director   –       •      –    2020-05-26 4 B $5.08 $101,600 D/D 20,000 95,000 2.39 266%     
   Fletcher Aaron G.l. Director   –       •      –    2020-04-15 4 B $4.72 $26,342 D/D 5,581 75,000 2.39 167%     
   Fletcher Aaron G.l. Director   –       •      –    2020-04-06 4 B $4.24 $26,508 D/D 6,252 69,419 2.39 151%     
   Fletcher Aaron G.l. Director   –       •      –    2020-04-03 4 B $3.97 $66,490 D/D 16,748 63,167 2.39 165%     
   Fletcher Aaron G.l. Director   –       •      –    2020-04-02 4 B $3.75 $1,875 D/D 500 46,419 2.31 144%     
   Fairbairn Malcolm Director   –       •      –    2020-01-27 3 IO $0.00 $0 I/I 0 1,392,568 5%     
   Mills Robert S Director   –       •      –    2019-10-29 4 A $0.00 $0 D/D 10,980 15,980     -
   Fletcher Aaron G.l. Director   –       •      –    2019-10-29 4 A $0.00 $0 D/D 43,919 45,919     -
   Mattes Glenn R. President and CEO   •       •      –    2019-10-25 4/A B $5.00 $50,000 I/I 10,000 10,000 2.66     -
   Coleman Kirk Allen CFO, Secretary, and Treasurer   •       –      –    2019-10-25 4 B $5.00 $5,000 D/D 1,000 1,000 2.74     -
   Weisman Harlan F Director   –       •      –    2019-10-25 4 B $5.00 $25,000 D/D 5,000 5,000 2.39     -
   Mills Robert S Director   –       •      –    2019-10-25 4 B $5.00 $25,000 D/D 5,000 5,000 2.39     -
   Windsor James Brian Chief Science Officer   •       •      –    2019-10-25 4 B $5.00 $25,000 D/D 5,000 5,000 2.81     -
   Fletcher Aaron G.l. Director   –       •      –    2019-10-25 4 B $5.00 $10,000 D/D 2,000 2,000 2.39     -
   Mattes Glenn R. President and CEO   •       •      –    2019-10-25 4 B $5.00 $50,000 D/D 10,000 10,000 2.81     -
   Thurman Randy H Director   –       •      –    2019-10-25 4 B $5.00 $25,000 D/D 5,000 5,000 2.39     -
   Lung Therapeutics, Inc. 10% Owner   –       –       •   2019-10-24 3 IO $0.00 $0 D/D 0 4,000,000     -

  93 Records found
  1  2  3  4    
  Page 4 of 4
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed